Search Within

Sadna Budhu

Formats
  1. Meeting Abstract (54)
  2. Journal Article (28)
  3. Book Section (1)
  4. Editorial (1)
  5. Research Letter (1)
  6. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (86)
  2. GSK Faculty (77)
  3. Department of Medicine (76)
  4. Solid Tumor Oncology Division (76)
  5. Melanoma and Immunotherapeutics Service (75)
  6. MSK Grad Students (25)

More Groups

People
  1. Taha Merghoub (75)
  2. Jedd Wolchok (69)
  3. Cailian Liu (30)
  4. Roberta Zappasodi (30)
  5. Hong Zhong (24)
  6. Daniel Hirschhorn Cymerman (20)

More People

Years
  1. 2023 (3)
  2. 2022 (12)
  3. 2021 (12)
  4. 2020 (8)
  5. 2019 (10)
  6. 2018 (14)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (22)
  2. Cancer Research (19)
  3. Journal of Immunology (9)
  4. Cancer Immunology Research (5)
  5. International Journal of Radiation Oncology, Biology, Physics (3)
  6. Cancer Cell (2)

More Publications

Publishers
  1. American Association for Cancer Research (25)
  2. Biomed Central Ltd (22)
  3. The American Association of Immunologists, Inc (9)
  4. Nature Publishing Group (6)
  5. Cell Press (5)
  6. Elsevier Inc. (4)

More Publishers

Results (86)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; DeHanau, O.; Mangarin, L. M.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Meeting Abstract

    Budha, S.; Giese, R.; Gupta, A.; De Henau, O.; Zappasodi, R.; Campesato, L. F.; Barker, C.; Shan, J.; Wolchok, J. D.; Merghoub, T.
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • Interaction between Kynurenine and the AhR is an effector mechanism of tumor immunosuppression and represents a potential immunotherapy target
    Meeting Abstract

    Campesato, L. F.; Budhu, S.; Tchaicha, J.; Pourpe, S.; Liu, C.; Manfredi, M. G.; McGovern, K.; Wolchok, J. D.; Merghoub, T.
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to radiation therapy and immune checkpoint blockade in a preclinical melanoma model
    Meeting Abstract

    Budhu, S.; Giese, R.; Gupta, A.; Schad, S.; De Henau, O.; Zappasodi, R.; Campesato, L.; Barker, C.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Rational combination of GITR agonism with PD-1 blockade in cancer patients
    Meeting Abstract

    Zappasodi, R.; Sirard, C.; Li, Y.; Budhu, S.; Abu-Akeel, M.; Liu, C.; Yang, X.; Zhong, H.; Newman, W.; Qi, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Cytokine release syndrome after radiation therapy: Case report and review of the literature
    Journal Article

    Barker, C. A.; Kim, S. K.; Budhu, S.; Matsoukas, K.; Daniyan, A. F.; D'Angelo, S. P.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Systemic antitumor immunity by PD-1/PD-L1 inhibition is potentiated by vascular-targeted photodynamic therapy of primary tumors
    Journal Article

    O'Shaughnessy, M. J.; Murray, K. S.; La Rosa, S. P.; Budhu, S.; Merghoub, T.; Somma, A.; Monette, S.; Kim, K.; Corradi, R. B.; Scherz, A.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save